| Company Name: Teikoku Seiyaku Co., Ltd. |
| Year of Establishment: 1848; reorganized into a joint-stock company in May 1918 |
| Capital: ¥122.694 million |
| Number of Employees: 693 (As of December 31, 2009) |
| Items of Business: Development, manufacturing and sales of medicated and medically related supplies |
| Board of Directors |
 |
Chairman: Shozo Akazawa |
| President & CEO: Shosaku Murayama |
| Executive Officer: Misako Fujioka |
| Senior Managing Director: |
|
Shinji Sano |
|
Information Processing, General Affairs, Finance & Accounting and Purchasing |
|
|
| Managing Director: |
|
Akihito Oji |
|
Production, Regulatory Affairs, QC and Health & Beauty Care Product Development |
|
|
| Executive Directors: |
|
Yoshihiko Akazawa |
| Ryota Akazawa |
| Ryoji Konishi |
|
Scientific Advisor, QA and Safety Management |
|
| Masahisa Kitagawa |
|
Teikoku Pharma USA, Inc. CEO |
|
| Kiyoshi Ohta |
|
Sales & Marketing Department |
|
| Tomomi Tada |
|
Secretarial Unit, Finance & Accounting and Purchasing |
|
| Takahiro Mimoto |
|
General Affairs |
|
|
| Auditors: |
|
Eiji Akazawa |
| Yutaka Saito |
|
|
| Headquarters: |
|
567 Sanbonmatsu, Higashikagawa, Kagawa 769-2695, Japan |
| Tel:+81-879-25-2221 |
| Fax:+81-879-24-1555 |
|
| Organization: Click here for details |
| Financial Statements: |
|
|
